The Advantage of PurMacept™ Lab Surface Sanitizer over Other Commercially Available Sanitizers

PurMacept™ Lab Surface Sanitizer generates free radicals that eliminate bacteria, fungi, viruses, and mycoplasma — delivering broad-spectrum lab decontamination that alcohol-based sanitizers simply cannot match.

🧪 Key Takeaways

  • Broad-spectrum free-radical elimination: PurMacept™ generates free radicals upon mixing that rapidly eliminate a wide spectrum of contaminants, including bacteria, fungi, viruses, and mycoplasma.

  • Safer alternative to alcohol: Prolonged inhalation of standard alcohol-based sanitizers in enclosed laboratory environments carries documented occupational risks, including respiratory irritation and neurocognitive effects. PurMacept™ is specifically formulated for safe use by personnel in these enclosed areas.

  • Superior multi-target mechanism: The sanitizer actively destroys the cell walls and membranes of organisms. For mycoplasma, it penetrates intracellularly to cause oxidative damage to nucleoid DNA/RNA and essential macromolecules.

  • Practical and stable format: The two-component, on-demand activation ensures maximum potency at the time of application and improves overall storage stability. Additionally, it is supplied as a cost-effective 10X concentrate , and applying it twice to a surface provides residual activity to help prevent pathogen regrowth.

  • Outperforms common disinfectants: It delivers improved mycoplasma control compared to alcohols and quaternary ammonium compounds. Furthermore, it is less corrosive and more stable than sodium hypochlorite (bleach) or pre-mixed oxidizers.

PurMacept™ Lab Surface Sanitizer (10X) is a proprietary two-component disinfectant from PurMa Biologics, developed from over 20 years of laboratory experience. When diluted and mixed, its components generate free radicals that rapidly eliminate a broad spectrum of contaminants — bacteria, fungi/yeast, viruses (including SARS-CoV-2), and mycoplasma — making it especially suited for cell culture and other sensitive laboratory environments. The free radicals persist for approximately two weeks as they are released gradually; therefore, prepare quantities that maximize use within this period and remix every two weeks. (Claim based on internal stability testing; subject to site validation.)

Background

Alcohol-based sanitizers (most commonly isopropanol) are widely used in laboratories due to low cost and ease of use. However, repeated or prolonged inhalation exposure — particularly in enclosed or poorly ventilated settings such as biosafety cabinets or small labs — carries documented occupational risks, including chronic respiratory irritation, neurocognitive effects (memory and concentration deficits, sleep disturbances, mood changes), potential neurotoxicity with high cumulative exposure, hepatic and renal strain, owing to metabolic burden, sensory impairment, exacerbation of preexisting respiratory or CNS conditions, and indirect dermal effects from vapor condensation. PurMacept™ has been formulated for safe use by personnel in enclosed areas when used according to instructions and PPE guidance.

Superior Mechanism of Action

  • Free-radical oxidative elimination: Upon activation, PurMacept™ generates reactive free radicals that induce multi-target oxidative damage to microbial components.
  • Cell wall and membrane disruption: For organisms with cell walls, PurMacept™ destroys the cell wall and membrane, causing lysis and elimination.
  • Mycoplasma elimination: For mycoplasma (which lack a cell wall), PurMacept™ disrupts the cell membrane and penetrates intracellularly to oxidatively damage nucleoid DNA/RNA and essential macromolecules, resulting in complete elimination.

Broad-Spectrum, Rapid Efficacy

  • Short required contact times to minimize workflow disruption.
  • Demonstrated activity against Gram-positive and Gram-negative bacteria, molds/yeasts, enveloped viruses (including SARS-CoV-2), and mycoplasma.
  • Reduced microbial rebound due to multi-target oxidative action.

Practical Advantages in the Laboratory

  • Concentrated, cost-effective 10X format (dilute 1:10).
  • If applied twice to a surface, residual activity of PurMacept™ helps prevent regrowth of common laboratory pathogens. (Claim subject to validation and routine environmental monitoring.)
  • Two-component, on-demand activation improves storage stability and assures potency at application.
  • Compatible with routine decontamination workflows for incubators, biosafety cabinets, benches, and other hard, non-porous surfaces.
  • Formulated for personnel safety when used with appropriate PPE and handling procedures.

Comparative Benefits versus Common Sanitizers

  • Improved mycoplasma control relative to quaternary ammonium compounds and alcohols.
  • Less corrosive and more stable than sodium hypochlorite (bleach) or pre-mixed oxidizers.
  • Broad coverage reduces the need for multiple specialized products.

Validated Mycoplasma Control and Escalation

  • Optimized for reliable mycoplasma elimination in routine environmental control.
  • For severe or persistent contamination, use PurMa™ MycoSpray (Cat#: P5M010405) as a targeted follow-up intervention.

Usage Recommendations

  • Dilution: Prepare working solution by diluting PurMacept™ concentrate 1:10 (1 part concentrate to 9 parts water) and mix components per label instructions.
  • Application: Apply by spray, wipe, or mop; ensure the recommended contact time is achieved before wiping or allowing surfaces to air dry.
  • PPE and controls: Use gloves and eye protection; ensure adequate ventilation and follow institutional chemical handling and disposal policies. Consult the SDS for complete safety information.

Conclusion

Built on two decades of PurMa Biologics’ expertise, PurMacept™ Lab Surface Sanitizer (10X) delivers a robust and laboratory-appropriate solution for eliminating contaminants in cell culture environments. Its two-component free-radical chemistry destroys cell walls and membranes and penetrates intracellular targets in mycoplasma, ensuring comprehensive elimination while supporting routine lab workflows and personnel safety.

References

  1. Burleigh-Flayer H.D., Gill M.W., Strother D.E., et al. (1994). Isopropanol 13-Week Vapor Inhalation Study in Rats and Mice with Neurotoxicity Evaluation in Rats. Toxicological Sciences, 23(3), 421–428.
  2. Soares Santos D., Nunes A.L., Matos A.L., et al. (2021). A Case of Liver Injury after Exposure to Isopropanol: A Challenging Diagnosis. GE Portuguese Journal of Gastroenterology. (PMCID: PMC8138187)
×
×

Cart

moji

Thankyou For Subscribing

The latest news and Updates from PurMa Biologics, LLC sent to you inbox